Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
clinical trials
fda
life sciences
national blog main
akouos
astellas pharmaceuticals
biotech ipos
boston top stories
california institute for biomedical research
deals
decibel therapeutics
dyne therapeutics
frequency therapeutics
harvard university
hearing loss
investing
jeffrey karp
metacrine
multiple sclerosis
myotonic dystrophy type 1
nonalcoholic steatohepatitis
perceptive life sciences
rare disease drugs
rare diseases
regenerative medicine
robert langer
salk institute
san diego blog main
san diego top stories
san francisco blog main
sensorineural hearing loss
taiwania capital management
the scripps research institute
ulcerative colitis
What
developing
2
×
drug
2
×
ipo
2
×
medicines
therapeutics
affects
americans
approved
brings
company
date
disorders
dyne
dyne’s
fda
frequency
genetic
hearing
loss
meds
million
millions
muscle
muscular
plans
preclinical
raised
rare
regenerative
stage
topped
treat
upsized
Language
unset
Current search:
developing
×
drug
×
ipo
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds